Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population

被引:65
作者
Bagli, M
Papassotiropoulos, A
Knapp, M
Jessen, F
Rao, ML
Maier, W
Heun, R
机构
[1] Univ Bonn, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany
[2] Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany
关键词
Alzheimer's disease; interleukin-6; promoter; variable number of tandem repeat; polymorphism; linkage disequilibrium; gene-gene interaction;
D O I
10.1016/S0304-3940(00)00917-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Several studies have demonstrated that interleukin-6 (IL-6) is involved in the pathogenesis of Alzheimer's disease (AD). We previously reported on an association between the C allele of a variable number of tandem repeat polymorphism in the 3' flanking region of IL-6 gene (IL-6vntr) and delayed initial onset and reduced AD risk. A novel G/C polymorphism at position -174 in the IL-6 gene promoter (IL-6prom) has recently been identified and appears to influence the regulation of IL-6 expression. We examined this functional polymorphism in 102 AD patients and two control groups of 191 healthy subjects and 160 depressed patients. There was no evidence for an allelic association between IL-6prom polymorphism and earlier age of onset or risk of AD. However, haplotype analysis showed a strong linkage disequilibrium between IL-6vntr and IL-6prom and demonstrated an interaction between IL-6vntr and IL-6prom which modifies AD risk. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 20 条
  • [1] RAPID DETECTION AND SEQUENCING OF ALLELES IN THE 3' FLANKING REGION OF THE INTERLEUKIN-6 GENE
    BOWCOCK, AM
    RAY, A
    ERLICH, H
    SEHGAL, PB
    [J]. NUCLEIC ACIDS RESEARCH, 1989, 17 (17) : 6855 - 6864
  • [2] BREITNER JCS, 1989, NEUROBIOL AGING, V17, P789
  • [3] Transgenic models to assess the pathogenic actions of cytokines in the central nervous system
    Campbell, IL
    Stalder, AK
    Chiang, CS
    Bellinger, R
    Heyser, CJ
    Steffensen, S
    Masliah, E
    Powell, HC
    Gold, LH
    Henriksen, SJ
    Siggins, GR
    [J]. MOLECULAR PSYCHIATRY, 1997, 2 (02) : 125 - 129
  • [4] The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
    Fishman, D
    Faulds, G
    Jeffery, R
    Mohamed-Ali, V
    Yudkin, JS
    Humphries, S
    Woo, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1369 - 1376
  • [5] Physiological and pathological roles of interleukin-6 in the central nervous system
    Gruol, DL
    Nelson, TE
    [J]. MOLECULAR NEUROBIOLOGY, 1997, 15 (03) : 307 - 339
  • [6] Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease
    Hampel, H
    Schoen, D
    Schwarz, MJ
    Kotter, HU
    Schneider, C
    Sunderland, T
    Dukoff, R
    Levy, J
    Padberg, F
    Stubner, S
    Buch, K
    Muller, N
    Moller, HJ
    [J]. NEUROSCIENCE LETTERS, 1997, 228 (03) : 143 - 146
  • [7] Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease:: Interleukin-1β, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-α, the soluble tumor necrosis factor receptors I and III, and α1-antichymotrypsin
    Lanzrein, AS
    Johnston, CM
    Perry, VH
    Jobst, KA
    King, EM
    Smith, AD
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (03) : 215 - 227
  • [8] INCREASED PLASMA-CONCENTRATIONS OF INTERLEUKIN-6, SOLUBLE INTERLEUKIN-6, SOLUBLE INTERLEUKIN-2 AND TRANSFERRIN RECEPTOR IN MAJOR DEPRESSION
    MAES, M
    MELTZER, HY
    BOSMANS, E
    BERGMANS, R
    VANDOOLAEGHE, E
    RANJAN, R
    DESNYDER, R
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1995, 34 (04) : 301 - 309
  • [9] ANTIINFLAMMATORY DRUGS AND ALZHEIMER-DISEASE
    MCGEER, PL
    MCGEER, E
    ROGERS, J
    SIBLEY, J
    [J]. LANCET, 1990, 335 (8696) : 1037 - 1037
  • [10] MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939